Similar articles for PMID: 23624289

Year	Number of Results
1989	1
1998	1
2000	1
2001	5
2004	3
2005	4
2007	6
2008	2
2009	3
2010	4
2011	5
2012	4
2013	6
2014	5
2015	7
2016	8
2017	4
2018	7
2019	9
2020	12
2021	7
2022	3
2023	4
2024	1

1

Opioids and their receptors: Are we there yet?

Pasternak GW. Pasternak GW. Neuropharmacology. 2014 Jan;76 Pt B(0 0):198-203. doi: 10.1016/j.neuropharm.2013.03.039. Epub 2013 Apr 26. Neuropharmacology. 2014. PMID: 23624289 Free PMC article. Review.

2

The pharmacology of mu analgesics: from patients to genes.

Pasternak GW. Pasternak GW. Neuroscientist. 2001 Jun;7(3):220-31. doi: 10.1177/107385840100700307. Neuroscientist. 2001. PMID: 11499401 Review.

3

Truncated G protein-coupled mu opioid receptor MOR-1 splice variants are targets for highly potent opioid analgesics lacking side effects.

Majumdar S, Grinnell S, Le Rouzic V, Burgman M, Polikar L, Ansonoff M, Pintar J, Pan YX, Pasternak GW. Majumdar S, et al. Proc Natl Acad Sci U S A. 2011 Dec 6;108(49):19778-83. doi: 10.1073/pnas.1115231108. Epub 2011 Nov 21. Proc Natl Acad Sci U S A. 2011. PMID: 22106286 Free PMC article.

4

Multiple opiate receptors: déjà vu all over again.

Pasternak GW. Pasternak GW. Neuropharmacology. 2004;47 Suppl 1:312-23. doi: 10.1016/j.neuropharm.2004.07.004. Neuropharmacology. 2004. PMID: 15464147 Review.

5

Mediation of opioid analgesia by a truncated 6-transmembrane GPCR.

Lu Z, Xu J, Rossi GC, Majumdar S, Pasternak GW, Pan YX. Lu Z, et al. J Clin Invest. 2015 Jul 1;125(7):2626-30. doi: 10.1172/JCI81070. Epub 2015 May 26. J Clin Invest. 2015. PMID: 26011641 Free PMC article.

6

Mu Opioid Pharmacology: 40 Years to the Promised Land.

Pasternak GW. Pasternak GW. Adv Pharmacol. 2018;82:261-291. doi: 10.1016/bs.apha.2017.09.006. Epub 2017 Nov 15. Adv Pharmacol. 2018. PMID: 29413524 Review.

7

Opioids in chronic pain.

Przewłocki R, Przewłocka B. Przewłocki R, et al. Eur J Pharmacol. 2001 Oct 19;429(1-3):79-91. doi: 10.1016/s0014-2999(01)01308-5. Eur J Pharmacol. 2001. PMID: 11698029 Review.

8

Molecular insights into mu opioid pharmacology: From the clinic to the bench.

Pasternak GW. Pasternak GW. Clin J Pain. 2010 Jan;26 Suppl 10(Suppl 10):S3-9. doi: 10.1097/AJP.0b013e3181c49d2e. Clin J Pain. 2010. PMID: 20026962 Free PMC article.

9

Replacement of current opioid drugs focusing on MOR-related strategies.

Busserolles J, Lolignier S, Kerckhove N, Bertin C, Authier N, Eschalier A. Busserolles J, et al. Pharmacol Ther. 2020 Jun;210:107519. doi: 10.1016/j.pharmthera.2020.107519. Epub 2020 Mar 9. Pharmacol Ther. 2020. PMID: 32165137 Review.

10

Exploring μ-Opioid Receptor Splice Variants as a Specific Molecular Target for New Analgesics.

Mizoguchi H, Fujii H. Mizoguchi H, et al. Curr Top Med Chem. 2020;20(31):2866-2877. doi: 10.2174/1568026620666200922113430. Curr Top Med Chem. 2020. PMID: 32962616 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

95 results

Results by year